Please enable JavaScript to experience the full functionality of GMX.

Neuralink shares ‘promising’ update in early human trials

Neuralink shares ‘promising’ update in early human trials

Neuralink believes it may have fixed one of the major problems found in its early human trials.

The Elon Musk-owned start-up company - which is developing a chip that, when implanted into the brain, will allow its user to complete tasks like play video games just by thinking of doing so - is currently on its second human patient called Alex, and has found that it has “observed no thread retraction” from the device in the participant’s brain.

In the business’ first patient earlier this year, Neuralink discovered some of the implants’ connective threads retracted from the brain weeks after the surgery, which reduced the brain signals the device could receive.

For Neuralink’s second patient, the company used several mitigation measures - such as reducing brain motion during the surgery and decreasing the gap between the implant and the surface of the brain - in an effort to combat this problem, and has not observed any threat retraction as of yet.

Since his operation in July, Alex has been able to use computer-aided design (CAD) software to create a custom mount for his Neuralink charger using the device.

The patient was also able to use the chip in conjunction with a mouth-operated joystick to play the video game ‘Counter-Strike 2’.

Neuralink has since confirmed it is working on making the device better at detecting and decoding multiple movements and clicks “to deliver full mouse and video game controller functionality”.

Sponsored Content

Related Headlines